Why Does This Pain Occur?
The most common cause of classic trigeminal neuralgia is a blood vessel (usually an artery) pressing on the trigeminal nerve at its exit point from the brainstem, gradually wearing down the nerve’s insulating layer; as a result the nerve turns even a light touch into a severe pain signal. Less often a condition such as multiple sclerosis, or a mass in the region, can produce a similar picture. Diagnosis rests largely on the typical pain pattern the patient describes; a high-resolution, thin-slice MRI is performed both to show the vessel–nerve relationship and to rule out another underlying cause (a tumor, an MS plaque). Correct diagnosis is the precondition for correct treatment — because not every facial pain is trigeminal neuralgia.
The First Step Is Not Surgery
The first option in treating trigeminal neuralgia is almost always medication. Ordinary painkillers do not work for this pain; the foundation of treatment is nerve-pain drugs such as carbamazepine or oxcarbazepine, which provide marked relief in many patients. However, these drugs can have side effects, may lose effect over time, or the patient may not tolerate the dose. Surgical options come to the fore when medication is inadequate, when intolerable side effects appear, or when the patient does not want to remain dependent on medication for life. So surgery is not a failure but the natural next step of a stepwise treatment.
Surgical Options: Which One for Whom?
In drug-resistant classic trigeminal neuralgia there are essentially two diverging paths. The first is microvascular decompression (MVD): an open operation performed behind the ear that addresses the cause; the vessel pressing on the nerve is found and a small cushion is placed between them to free the nerve. It requires general anesthesia and a few days’ stay, but has the potential to give the most lasting result in suitable patients, with a low risk of facial numbness. The second path is nerve-directed percutaneous procedures (radiofrequency, balloon compression, glycerol) and Gamma Knife radiosurgery; these are less invasive, suitable for older patients or those with other illnesses, but may leave effects such as facial numbness and the pain can recur over time. Which path is chosen is decided together with the patient’s age, general condition, MRI findings and expectations.
The Procedure and Afterwards
In microvascular decompression the patient is put under general anesthesia, a small window is opened behind the ear, and the nerve–vessel relationship is corrected under the microscope; the procedure takes a few hours and usually involves a few days’ hospital stay. Percutaneous procedures are mostly short and done under light sedation, with the patient often discharged the same or the next day. Gamma Knife requires no incision and is completed in a single session, but its effect emerges slowly over days to weeks. Whichever method is chosen, the speed and durability of pain control differ by method; these differences are discussed openly with you before the procedure.
Realistic Expectations and Risks
The aim in treating trigeminal neuralgia is to stop the unbearable attacks and restore quality of life; in appropriately selected patients the rate of reaching this goal is high. However, no method can guarantee “lifelong freedom from pain” — the pain can recur after a while, and if needed treatment can be repeated or another method chosen. Each option has its own risks: open surgery carries risks of bleeding, hearing effects or rare neurological loss; percutaneous and radiosurgical methods more commonly cause facial numbness. For this reason the “best method” is not the same for everyone; we determine the most suitable one for you together with your expectations and risk tolerance.